BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38668730)

  • 1. Ex vivo gene editing and cell therapy for hereditary tyrosinemia type 1.
    Ates I; Stuart C; Rathbone T; Barzi M; He G; Major AM; Shankar V; Lyman RA; Angner SS; Mackay TFC; Srinivasan S; Farris AB; Bissig KD; Cottle RN
    Hepatol Commun; 2024 May; 8(5):. PubMed ID: 38668730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curative Ex Vivo Hepatocyte-Directed Gene Editing in a Mouse Model of Hereditary Tyrosinemia Type 1.
    VanLith C; Guthman R; Nicolas CT; Allen K; Du Z; Joo DJ; Nyberg SL; Lillegard JB; Hickey RD
    Hum Gene Ther; 2018 Nov; 29(11):1315-1326. PubMed ID: 29764210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reprogramming metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia.
    Pankowicz FP; Barzi M; Legras X; Hubert L; Mi T; Tomolonis JA; Ravishankar M; Sun Q; Yang D; Borowiak M; Sumazin P; Elsea SH; Bissig-Choisat B; Bissig KD
    Nat Commun; 2016 Aug; 7():12642. PubMed ID: 27572891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curative ex vivo liver-directed gene therapy in a pig model of hereditary tyrosinemia type 1.
    Hickey RD; Mao SA; Glorioso J; Elgilani F; Amiot B; Chen H; Rinaldo P; Marler R; Jiang H; DeGrado TR; Suksanpaisan L; O'Connor MK; Freeman BL; Ibrahim SH; Peng KW; Harding CO; Ho CS; Grompe M; Ikeda Y; Lillegard JB; Russell SJ; Nyberg SL
    Sci Transl Med; 2016 Jul; 8(349):349ra99. PubMed ID: 27464750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficient liver repopulation of transplanted hepatocyte prevents cirrhosis in a rat model of hereditary tyrosinemia type I.
    Zhang L; Shao Y; Li L; Tian F; Cen J; Chen X; Hu D; Zhou Y; Xie W; Zheng Y; Ji Y; Liu M; Li D; Hui L
    Sci Rep; 2016 Aug; 6():31460. PubMed ID: 27510266
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative Stress, Glutathione Metabolism, and Liver Regeneration Pathways Are Activated in Hereditary Tyrosinemia Type 1 Mice upon Short-Term Nitisinone Discontinuation.
    Colemonts-Vroninks H; Neuckermans J; Marcelis L; Claes P; Branson S; Casimir G; Goyens P; Martens GA; Vanhaecke T; De Kock J
    Genes (Basel); 2020 Dec; 12(1):. PubMed ID: 33375092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cas9-nickase-mediated genome editing corrects hereditary tyrosinemia in rats.
    Shao Y; Wang L; Guo N; Wang S; Yang L; Li Y; Wang M; Yin S; Han H; Zeng L; Zhang L; Hui L; Ding Q; Zhang J; Geng H; Liu M; Li D
    J Biol Chem; 2018 May; 293(18):6883-6892. PubMed ID: 29507093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complete rescue of lethal albino c14CoS mice by null mutation of 4-hydroxyphenylpyruvate dioxygenase and induction of apoptosis of hepatocytes in these mice by in vivo retrieval of the tyrosine catabolic pathway.
    Endo F; Kubo S; Awata H; Kiwaki K; Katoh H; Kanegae Y; Saito I; Miyazaki J; Yamamoto T; Jakobs C; Hattori S; Matsuda I
    J Biol Chem; 1997 Sep; 272(39):24426-32. PubMed ID: 9305902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A mouse model of renal tubular injury of tyrosinemia type 1: development of de Toni Fanconi syndrome and apoptosis of renal tubular cells in Fah/Hpd double mutant mice.
    Sun MS; Hattori S; Kubo S; Awata H; Matsuda I; Endo F
    J Am Soc Nephrol; 2000 Feb; 11(2):291-300. PubMed ID: 10665936
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kidneys of mice with hereditary tyrosinemia type I are extremely sensitive to cytotoxicity.
    Jacobs SM; van Beurden DH; Klomp LW; Berger R; van den Berg IE
    Pediatr Res; 2006 Mar; 59(3):365-70. PubMed ID: 16492973
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue-specific FAH deficiency alters sleep-wake patterns and results in chronic tyrosinemia in mice.
    Yang S; Siepka SM; Cox KH; Kumar V; de Groot M; Chelliah Y; Chen J; Tu B; Takahashi JS
    Proc Natl Acad Sci U S A; 2019 Oct; 116(44):22229-22236. PubMed ID: 31611405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype.
    Yin H; Xue W; Chen S; Bogorad RL; Benedetti E; Grompe M; Koteliansky V; Sharp PA; Jacks T; Anderson DG
    Nat Biotechnol; 2014 Jun; 32(6):551-3. PubMed ID: 24681508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Electroporation-Mediated Delivery of Cas9 Ribonucleoproteins Results in High Levels of Gene Editing in Primary Hepatocytes.
    Rathbone T; Ates I; Fernando L; Addlestone E; Lee CM; Richards VP; Cottle RN
    CRISPR J; 2022 Jun; 5(3):397-409. PubMed ID: 35238624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Renal proximal tubular cells acquire resistance to cell death stimuli in mice with hereditary tyrosinemia type 1.
    Luijerink MC; van Beurden EA; Malingré HE; Jacobs SM; Grompe M; Klomp LW; Berger R; van den Berg IE
    Kidney Int; 2004 Sep; 66(3):990-1000. PubMed ID: 15327392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High volume naked DNA tail-vein injection restores liver function in Fah-knock out mice.
    Eggenhofer E; Doenecke A; Renner P; Slowik P; Piso P; Geissler EK; Schlitt HJ; Dahlke MH; Popp FC
    J Gastroenterol Hepatol; 2010 May; 25(5):1002-8. PubMed ID: 20546455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1.
    Li L; Zhang Q; Yang H; Zou Q; Lai C; Jiang F; Zhao P; Luo Z; Yang J; Chen Q; Wang Y; Newsome PN; Frampton J; Maxwell PH; Li W; Chen S; Wang D; Siu TS; Tam S; Tse HF; Qin B; Bao X; Esteban MA; Lai L
    J Biol Chem; 2017 Mar; 292(11):4755-4763. PubMed ID: 28053091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Animal models reveal pathophysiologies of tyrosinemias.
    Endo F; Tanaka Y; Tomoeda K; Tanoue A; Tsujimoto G; Nakamura K
    J Nutr; 2003 Jun; 133(6 Suppl 1):2063S-2067S. PubMed ID: 12771366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous Gene and Cell Therapy Provides Safe and Long-Term Curative Therapy in A Large Pig Model of Hereditary Tyrosinemia Type 1.
    Hickey RD; Nicolas CT; Allen K; Mao S; Elgilani F; Glorioso J; Amiot B; VanLith C; Guthman R; Du Z; Chen H; Harding CO; Kaiser RA; Nyberg SL; Lillegard JB
    Cell Transplant; 2019 Jan; 28(1):79-88. PubMed ID: 30477316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. All-in-one adeno-associated virus delivery and genome editing by Neisseria meningitidis Cas9 in vivo.
    Ibraheim R; Song CQ; Mir A; Amrani N; Xue W; Sontheimer EJ
    Genome Biol; 2018 Sep; 19(1):137. PubMed ID: 30231914
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological rescue of the 14CoS/14CoS mouse: hepatocyte apoptosis is likely caused by endogenous oxidative stress.
    Dieter MZ; Freshwater SL; Miller ML; Shertzer HG; Dalton TP; Nebert DW
    Free Radic Biol Med; 2003 Aug; 35(4):351-67. PubMed ID: 12899938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.